Avifavir: Russia’s Highly Effective Coronavirus Drug

Do you like "Our World"? Get notified when we publish something new.
Be sure to like our Facebook Page, Our World for more news and commentaries from around the world.

This article was first published on the 12th of July, 2020 by Patrick Carpen.

Last updated: July 12, 2020 at 10:32 am

Russia has been hit hard by the novel coronavirus – COVID-19. As of today, 12th of July, 2020, Russia has had over 700,000 registered coronavirus cases and over 11,000 coronavirus related deaths.

But Russia has fired back – releasing Avifavir – one of the only two registered coronavirus drugs in the world – which it expects to go commercial early August 2020.

In early June 2020, Russian Direct Investment Fund (RDIF) on Chemrar Group delivered the first batch of Avifavir to Russian hospitals.

This news comes on the heal of Bharat Biotech’s announcement that it is expected to release COVAXIN – a coronavirus vaccine, on August 15.